Acute Pathology of the Locomotor System
Conditions
Brief summary
The aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependence compared to a management according to the usual modalities in the rheumatology services concerned.
Interventions
OTHERpersonalized pharmaceutical plan
multi-professional intervention around strong opioid treatment with targeted pharmaceutical interview
Sponsors
University Hospital, Rouen
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient hospitalized in the rheumatology department * Patient with acute pain in the context of a non-cancerous, non-traumatic, high-energy musculoskeletal pathology * Patient for whom a prescription of strong opioid derivatives is initiated in rheumatology or patient for whom a prescription of strong opioid derivatives is maintained in rheumatology if the initial prescription has a maximum duration of 30 consecutive days prior to inclusion
Exclusion criteria
* Patient with cancer or fibromyalgia already diagnosed at inclusion * Patient with poor French language skills * Taking a strong opioid treatment for more than 30 consecutive days prior to inclusion * Person judged by the prescriber or pharmacist as not autonomous for the management of strong opioid treatment * Patient already included in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total duration of treatment in days with strong opioids from day of inclusion | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| number of patients exceeding the optimal duration of treatment with strong opioids defined by the SFETD learned society (French Society for the Study and Treatment of Pain) (3 months) | 3 months |
| pain assessment (numerical scale) at first patient call after stopping strong opioids | 6 months |
| number of patients exceeding the optimal duration of treatment with strong opioids defined by the CLUD (Pain Control Committee) of Rouen University Hospital (28 days) | 28 days |
Countries
France
Contacts
CONTACTCatherine CHENAILLER
CONTACTArmelle GUIDOTTI
PRINCIPAL_INVESTIGATORCatherine CHENAILLER
University Hospital, Rouen
Outcome results
None listed